BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 29197615)

  • 1. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic Relevance of Human Microbiota and Lung Cancer].
    Zhou H; Suo J; Zhu J
    Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):464-469. PubMed ID: 31315786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lung and gut microbiota on lung cancer pathogenesis.
    Zhao Y; Liu Y; Li S; Peng Z; Liu X; Chen J; Zheng X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2177-2186. PubMed ID: 34018055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the lung microbiome in HIV pathogenesis.
    Shenoy MK; Lynch SV
    Curr Opin HIV AIDS; 2018 Jan; 13(1):45-52. PubMed ID: 29035946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms.
    Xu N; Wang L; Li C; Ding C; Li C; Fan W; Cheng C; Gu B
    Transl Lung Cancer Res; 2020 Aug; 9(4):1554-1568. PubMed ID: 32953527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy.
    Khan FH; Bhat BA; Sheikh BA; Tariq L; Padmanabhan R; Verma JP; Shukla AC; Dowlati A; Abbas A
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):732-742. PubMed ID: 34273520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.
    Wu BG; Segal LN
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway Microbiota as a Modulator of Lung Cancer.
    Goto T
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Lung Microbiome on the Way to Cancer.
    Kovaleva OV; Romashin D; Zborovskaya IB; Davydov MM; Shogenov MS; Gratchev A
    J Immunol Res; 2019; 2019():1394191. PubMed ID: 31485458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human microbiome in rheumatic autoimmune diseases: A comprehensive review.
    Coit P; Sawalha AH
    Clin Immunol; 2016 Sep; 170():70-9. PubMed ID: 27493014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis.
    Costello ME; Robinson PC; Benham H; Brown MA
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):202-12. PubMed ID: 26362739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
    Olteanu G; Ciucă-Pană MA; Busnatu ȘS; Lupuliasa D; Neacșu SM; Mititelu M; Musuc AM; Ioniță-Mîndrican CB; Boroghină SC
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.